Davida F. Kruger, MSN, APRN-BC, BC-ADM to Receive the American Diabetes Association’s 2017 Outstanding Educator in Diabetes Award


Michelle Kirkwood

Arlington, Virginia
May 17, 2017

Davida F. Kruger, MSN, APRN-BC, BC-ADM, is the recipient of the American Diabetes Association (Association) 2017 Outstanding Educator in Diabetes Award. This award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes and has demonstrated significant contributions to the understanding of diabetes education. Kruger will be recognized with this honor during the Association’s 77th Scientific Sessions, June 9-13, 2016, at the San Diego Convention Center. She will deliver the Outstanding Educator in Diabetes Award Lecture titled, “A Toast To Our History,” on Saturday, June 10.

A Nurse Practitioner in diabetes research and clinical practice at Henry Ford Health System in Detroit, Kruger is being recognized for more than three decades of pivotal contributions to diabetes research, care and education. Her contributions to diabetes research are featured in more than 80 publications. Notably, she led the coordinators’ group for the national Diabetes Control and Complications Trial (DCCT), successfully implementing the trial across the U.S. With a passion for people with diabetes and those who care for them, Kruger has been a leader in patient care and education, and in the education of health care providers, endocrine fellows and researchers.

“Congratulations, Ms. Kruger, and thank you for your work, advocacy and longstanding commitment to people with diabetes and those who care for them,” said the Association’s President of Health Care and Education Brenda Montgomery, RN, MSHS, CDE¹. “From research, to volunteer leadership, to education and to care, Ms. Kruger has dedicated her career to improving the lives of people with diabetes, and we salute her efforts.”

Ms. Kruger’s commitment to diabetes is further evidenced by her volunteer leadership roles for the American Diabetes Association, including serving as Past-President of Health Care and Education, Past-Chair of the Research Foundation, and completed terms of service as editor-in-chief of two journals, Diabetes Spectrum and Clinical Diabetes.

The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE, President of Health Care and Education, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)

1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.